Thursday 10 July 2025

Keurig Dr Pepper announces pricing of secondary offering of common stock by JAB

Following the completion of the offering, JAB will beneficially own approximately 4.4% of KDP's outstanding common stock. The remaining shares beneficially owned by JAB will be subject to a 60-day lock-up agreement with the underwriter

Must read

TME - Cialdy Evo

 

Share your coffee stories with us by writing to info@comunicaffe.com.

BURLINGTON, Mass. and FRISCO, USA – Keurig Dr Pepper announced today the pricing of its previously-announced registered public offering of 75,000,000 shares through a secondary offering by a subsidiary of JAB Holding Company s.a.r.l. (“JAB”), at a price to the public of $33.45 per share.

Following the completion of the offering, JAB will beneficially own approximately 4.4% of Keurig Dr Pepper ‘s outstanding common stock. The remaining shares beneficially owned by JAB will be subject to a 60-day lock-up agreement with the underwriter.

Amcor

J.P. Morgan is acting as the underwriter for the secondary offering.

The offering will be made only by means of an effective registration statement and a prospectus. The Company has previously filed with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement (including a prospectus) on Form S-3 (File No. 333-266989) and a prospectus supplement, each dated August 19, 2022, as well as a preliminary prospectus supplement for the offering to which this communication relates.

Before you invest, you should read the prospectus in that registration statement, the accompanying prospectus supplements and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering.

The offering will be made only by means of a prospectus and related prospectus supplements relating to the offering, copies of which may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 866-803-9204 or by email at prospectus-eq_fi@jpmchase.com. These documents can also be accessed through the SEC’s website at www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Latest article

Demuslab